Next Article in Journal
Form Follows Function: Structural and Catalytic Variation in the Class A Flavoprotein Monooxygenases
Previous Article in Journal
Genomic DNA Methylation Changes in NYGGF4-Overexpression 3T3-L1 Adipocytes
Int. J. Mol. Sci. 2012, 13(12), 15588-15600; doi:10.3390/ijms131215588
Review

Elevated Levels of Lewis Y and Integrin α5β1 Correlate with Chemotherapeutic Drug Resistance in Epithelial Ovarian Carcinoma

,
,
,
,
,
,
,
,
 and
*
Department of Obstetrics and Gynecology, Shengjing Hospital affiliated to China Medical University, Shenyang 110004, Liaoning Province, China
* Author to whom correspondence should be addressed.
Received: 22 October 2012 / Revised: 9 November 2012 / Accepted: 12 November 2012 / Published: 23 November 2012
View Full-Text   |   Download PDF [645 KB, 19 June 2014; original version 19 June 2014]   |   Browse Figures

Abstract

Objective: To measure Lewis y and integrin α5β1 expression in epithelial ovarian carcinoma and to correlate the levels of these molecules with ovarian carcinoma chemotherapy and prognosis. Methods: The study population included 34 ovarian carcinoma patients with chemotherapeutic drug-resistance, six partially drug-sensitive cases, and 52 drug-sensitive cases (92 total). Immunochemistry was used to determine expression of Lewis y antigen and integrin α5β1 in ovarian carcinoma tissues, and correlation of these molecules with chemotherapy resistance was further investigated, Multi-factor logistic regression analysis was applied to investigate: age, surgical stage, grade, subtype of patient cases, metastasis of lymph nodes, residual tumor size, expression levels of Lewis y antigen and integrin α5β1 correlation with ovarian carcinoma chemotherapy resistance. Results: The expression rates of Lewis y antigen and integrins α5 and β1 were significantly greater in the drug-resistant group (91.17%, 85.29%, 88.24%) than the partially sensitive (50.00%, 33.33%, 50.00%) or sensitive groups (61.54%, 57.69%, 55.77%). Binary logistic regression analysis revealed that surgical stage, residual tumor size, and expression of integrin α5 and Lewis y in ovarian carcinoma tissues were independent risk factors for chemotherapeutic drug resistance. Conclusions: Overexpression of Lewis y and integrin α5 are strong risk factors for chemotherapeutic drug resistance in ovarian carcinoma patients.
Keywords: integrins; Lewis y antigen; ovarian caricinoma; chemoresistance integrins; Lewis y antigen; ovarian caricinoma; chemoresistance
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).
SciFeed

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
EndNote |
RIS
MDPI and ACS Style

Hu, Z.; Gao, S.; Gao, J.; Hou, R.; Liu, C.; Liu, J.; Li, B.; Liu, D.; Zhang, S.; Lin, B. Elevated Levels of Lewis Y and Integrin α5β1 Correlate with Chemotherapeutic Drug Resistance in Epithelial Ovarian Carcinoma. Int. J. Mol. Sci. 2012, 13, 15588-15600.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here

Comments

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert